United States Department of Defense
1400 Defense Pentagon, Room 1E757
11 articles with United States Department of Defense
Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University
Patient enrollment expected to commence in mid 2019
As we end October and head into November, the Food and Drug Administration (FDA) continues its work. This upcoming week has several PDUFA action dates for drug applications. Here’s a look.
Research award will support preclinical activities to advance product candidate for the treatment of interstitial cystitis/bladder pain syndrome into the clinic
BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products
BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products.
The U.S. Food and Drug Administration (FDA) cleared Cleveland-based SPR Therapeutics’ SPRINT endura (single lead) and extensa (dual lead) Peripheral Nerve Stimulation (PNS) Systems for controlling pain.
Revolutions Medical Corporation's RevVac Safety Syringe is Cleared by United States Department of Defense Logistics Agency for Inclusion in Medical Supply Catalog
Morphotek Inc. Receives Additional $1.6M in Funding from The United States Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons
Morphotek Inc. Receives $1.7M in Funding from the Morphotek Inc. to Develop Therapeutic Antibodies Against Microbial Bioweapons
Ultra-Scan Corporation Release: Ultra-Scan(TM) Ultrasonic Biometric Readers Pass Military, UL, FCC And European Testing Standards